NEEDHAM, Mass., Oct. 12, 2020 /PRNewswire-PRWeb/ — Over the past 27 years, Molecular Medicine Tri-Conference has served as the leading international meeting place for the precision medicine community. In 2021, TRI-CON attendees will join over 3,000 international thought leaders to discuss the latest research and technologies in COVID-19 diagnostics and vaccines, point-of-care diagnostics, biomarkers and liquid biopsy, data analytics and artificial intelligence, and immuno-oncology and cell therapy. In addition to the leading research and technology presentations you have come to expect at the Tri-Con, we have added structured networking opportunities and the free technology Expo, for a comprehensive 3-day program designed to maximize collaboration and innovation.

“Cambridge Healthtech Institute once again takes the leadership role of bringing together the life science community at the Virtual Conference & Expo 2021,” said Julia Boguslavsky, Executive Conference Director of Tri-Con. “We are inspired by the response of the precision medicine community — their eagerness to share their expertise while practicing social distancing, and by their commitment to furthering the biopharmaceutical research and developments needed to advance medical science and improve lives.”

Molecular Med Tri-Conference is taking place virtually February 16-18, 2021. To view event programs, distinguished speakers, and networking opportunities please visit http://www.TriConference.com.

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Meeting Planners and Healthtech Publishing, which includes Bio-IT World, Clinical Informatics News and Diagnostics World.

SOURCE Cambridge Healthtech Institute